A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
Completed · Phase 1
Conditions studied: Healthy Participants
In brief
Eptinezumab is a preventive treatment for migraine. The drug is made from a process that currently uses yeast cells for production of the drug. The trial researchers want to test whether using a new production cell line to make eptinezumab will affect the way the drug behaves in the body. To do this, the researchers will give a single dose of eptinezumab to healthy participants. Some of the participants will get eptinezumab that has been made from yeast cells. Others will get eptinezumab made with the new cell line.
Key facts
- Study ID
- NCT05074459
- Run by
- H. Lundbeck A/S
- People needed
- 84
- Starts
- 2021-09-27
- Expected to finish
- 2022-07-18
- Last updated by the study team
- 2022-08-29
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Labcorp Clinical Research Unit, Inc. — Daytona Beach, Florida, United States
- Labcorp Clinical Research Unit, Inc. — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.